The landscape of dementia analysis has advanced dramatically with the advent of sophisticated biomarkers, such as amyloid PET scans, tau imaging, and blood-based tests that could detect Alzheimer's pathology several years ahead of signs or symptoms arise. Although these technological developments symbolize outstanding progress in knowing neurodegenerative ailments, they have https://aaronp641oyh0.wikipowell.com/user